Table of Contents
Survey: HR Leaders Challenged with Employee Mental Health Needs
Uprise Health research provides new ways for benefits brokers to…
Learn More
Understanding the Connection: Mental Health’s Impact on Physical Health
In the intricate balance of well-being, the relationship between mental…
Learn More
Preventative Care: Take Control of Your Health
In the hustle and bustle of our daily lives, health…
Learn MoreAuthors: Zaller, N.; Yokell, M. A.; Green, T. C.
Substance Use & Misuse, Volume 48, 2013 – Issue 8
This study analyzed qualitative data from a Rapid Policy Assessment and Response project to assess the feasibility of a potential pharmacy-based naloxone intervention to reduce opioid overdose mortality among injection drug users (IDUs). We conducted in-depth, semistructured interviews with 21 IDUs and 21 pharmacy staff (pharmacists and technicians). Although most participants supported the idea of a pharmacy-based naloxone intervention, several barriers were identified, including misinformation about naloxone, interpersonal relationships between IDUs and pharmacy staff, and costs of such an intervention. Implications for future pharmacy-based overdose prevention interventions for IDUs, including pharmacy-based naloxone distribution, are considered. The study’s limitations are noted.